While there was a decrease in CD19+ splenocytes in 4T1 tumor-bearing mice compared with naïve mice or mice bearing non-metastatic 67NR tumors, we observed an unexpected increase in splenocytes that were positive for CD79-11 in 4T1 tumor-bearing mice (Figure 2A). Here, CD19 is linked to neoplasm.